Growth hormone and fluid retention

Hormone Research

Volumn 51, Issue SUPPL. 3, 1999, Pages 116-120

  Møller, Jens ^a,b   Nielsen, Sten ^a   Hansen, Troels Krarup ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b SILKEBORG REGIONAL HOSPITAL   (Denmark)

Author keywords

ANF; Fluid retention; Growth hormone; Renin angiotensin aldosterone system

Indexed keywords

GROWTH HORMONE; SODIUM;

CONFERENCE PAPER; ELECTROLYTE DISTURBANCE; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; HUMAN; PLASMA VOLUME; PRIORITY JOURNAL; SODIUM BALANCE; TOTAL BODY WATER;

EID: 0032741224     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053173     Document Type: Conference Paper

References (54)

1. Ikkos D, Luft R, Sjögren B: Body water and sodium in patients with acromegaly. J Clin Invest 1954;33:989-994.
2. Ikkos D, Luft R, Gemzell C-A: The effect of human growth hormone in man. Acta Endocrinol 1959;32:341-361.
3. Hewitt LF: Hormones of the anterior pituitary lobe. Biochem J 1929;23:718-725.
4. Jørgensen JO, Pedersen SA, Thuesen L, Hensen TI, Skakkebaek NE, Christiansen JS, Ingemann-Hansen T: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;i:1221-1225.
5. Salomon F, Cuneo RC, Hesp R, Sönksen PH: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321: 1797-1803.
6. de Boer H, Blok GJ, van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63-86.
7. Møller J, Jørgensen JOL, Laursen T, Frystyk J, Christiansen JS, Naeraa RW, Orskov H: Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) 1993;39:403-408.
8. de Boer H, Blok GJ, Voerman HJ, De Vries PM, Popp-Snijders C, van der Veen EA: The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J Clin Endocrinol Metab 1995;80:2069-2076.
9. Rosén T, Bosæus I, Tölli J, Lindstedt G, Bcngtsson B-Å: Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol 1993;38:63-71.
10. Møller J, Frandsen E, Fisker S, Jørgensen JOL, Christiansen JS: Decreased plasma and extracellular volume in GH deficient adults and the acute and prolonged effects of GH administration. A controlled experimental study. Clin Endocrinol (Oxf) 1996;44:533-539.
11. Binnerts A, Deurenberg P, Swart GR, Wilson JH, Lamberts SW: Body composition in growth hormone-deficient adults. Am J Clin Nutr 1992;55:918-923.
12. Hoffman DM, Crampton L, Sernia C, Nguyen TV, Ho KY: Short term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab 1996; 81:1123-1128.
13. Janssen YJH, Deurenberg P, Roelfsema F: Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficicnt adults. J Clin Endocrinol Metab 1997;82:3349-3355.
14. van Wouters D. van Marken Lichtenbelt WD, Snel YE, Brummer RJ, Koppeschaar HP: Deuterium and bromide dilution, and bioimpedance spectrometry independently show that growth hormone-deficient adults have an enlarged extracellular water compartment related to intracellular water. J Clin Endocrinol Metab 1997;82:907-911.
15. Snel YE, Brummer RJ. Bol E, Doerga ME, Zelissen PM, Zonderland ML. Boer P, Koomans HA, Koppeschaar HP: Direct assessment of extracellular water volume by the bromidedilution method in growth hormone-deficient adults. Eur J Clin Invest 1995;25:708-714.
16. de Boer H, Blok GJ, Voerman HJ, de Vries PM, van der Veen EA: Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab 1992;75:833-837.
17. Møller J, Rosenfalch AM, Fisker S, Jørgensen JOL, Hilsted J. Christiansen JS: The impact of 4 months' GH substitution on body fluid distribution in adult GH deficient patients (abstract). Endo Soc 1997.OR 20-24.
18. Bengtsson B-Å, Edén S, Lönn L, Kvist H, Stokland A, Linstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-317.
19. Cuneo RC, Salomon F. McGauley GA, Sönksen PH: The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 1992; 37:387-397.
20. Falkheden T, Sjögren B: Extracellular fluid volume and renal function in pituitary insufficiency and acromegaly. Acta Endocrinol (Copenh) 1964;46:80-88.
21. Bengtsson B-Å, Brummer RJ, Edén S, Bosæus I. Lindstedt G: Body composition in acromegaly: the effect of treatment. Clin Endocrinol (Oxf) 1989;31:481-490.
22. Finn PJ, Plank LD, Clark MA, Connolly AB, Hill GL: Progressive cellular dehydration and proteolysis in critically ill patients. Lancet 1996;347:654-656.
23. Garrison RN, Wilson MA, Matheson PJ, Spain DA: Preoperative saline loading improves outcome after elective, noncardiac surgical procedures. Am Surg 1996;62:223-231.
24. Sinclair S, James S, Singer M: Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. Br Med J 1997;315:909-912.
25. Gatzen C, Scheltinga MR, Kimbrough TD, Jacobs DO, Wilmore DW: Growth hormone attenuates the abnormal distribution of body water in critically ill patients. Surgery 1992;112: 181-187.
26. Møller J, Jensen MB, Frandsen E, Møller N, Kissmeyer P, Laurberg S: Growth hormone treatment improves body fluid distribution in patients undergoing elective abdominal surgery. Clin Endocrinol (Oxf) 1998;47:112-117.
27. White HL, Heinbecker P, Rolf D: Enhancing effects of growth hormone on renal function. Am J Physiol 1949;157:47-51.
28. Parving HH, Noer I, Mogensen CE, Svendsen PA: Kidney function in normal man during short-term growth hormone infusion. Acta Endocrinol (Copenh) 1978;89:796-800.
29. Guler HP, Schmid C, Zapf J, Froesch ER: Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 1989;86:2868-2872.
30. Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER: Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 1989;121:101-106.
31. Hirschberg R. Brunori G, Kopple JD, Guler HP: Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 1993;43:387-397.
32. Venning EH, Lucis OJ: Effect of growth hormone on the biosynthesis of aldosterone in the rat. Endocrinology 1962;20:486-491.
33. Ho KY, Weissberger AJ: The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 1990;39:133-137.
34. Møller J, Jørgensen JOL, Frandsen E, Laursen T, Christiansen JS: Body fluids, circadian blood pressure, and plasma renin during growth hormone administration: a placebo controlled study with two growth hormone doses in healthy adults. Scand J Clin Lab Invest 1995;55:663-669.
35. Cuneo RC, Salomon F, Wilmshurst P, Byrne C, Wiles CM, Hesp R, Sonksen PH: Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci 1991; 81:587-592.
36. Herlitz H, Jonsson O, Bengtsson B-Å: Effect of recombinant human growth hormone on cellular sodium metabolism. Clin Sci 1994;86:233-237.
37. Ross EJ, van't Hoff W, Crabbe J, Thorn GW: Aldosterone excretion in hypopituitarism and after hypophysectomy in man. Am J Med 1960;62:229-238.
38. Birkhauser M, Gaillard R, Riondel AM, Zahnd GR: Influence of acute administration of growth hormone and alpha-MSH on plasma concentrations of aldosterone, cortisol, corticosterone and growth hormone in man. Acta Endocrinol (Copenh) 1975;79:16-24.
39. Møller J, Jørgensen JO, Møller N, Hansen KW, Pedersen EB, Christiansen JS: Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab 1991;72:768-772.
40. DiMartino-Nardi J, Wesoly S, Schwartz L, Saenger P: Lack of clinical evidence of sodium retention in children with idiopathic short stature treated with recombinant growth hormone. Metabolism 1993;42:730-734.
41. Pratt JH, Peacock M, Henry DP: Effect of recombinant human growth hormone on adreno-cortical function, and on sodium and potassium homeostasis. Pharmacology 1993;47:36-42.
42. Barton JS, Hindmarsh PC, Preece MA, Brook CGD: Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone. Clin Endocrinol 1993;38:245-251.
43. Strauch G, Vallotton MB, Touitou Y, Bricaire H: The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly. N Engl J Med 1972;287:795-799.
44. Karlberg BE, Ottosson AM: Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol (Copenh) 1982;100:581-587.
45. Thompson JL, Butterfield GE, Marcus R, Hintz RL, Van Loan M, Ghiron L, Hoffman AR: The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 1995;80:1845-1852.
46. Thompson JL, Butterfield GE, Gylfadottir UK, Yesavage J, Marcus R, Hintz RL, Pearman A, Hoffman AR: Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab 1998;83:1477-1484.
47. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
48. McKnight JA, McCance DR, Hadden DR, Kennedy L, Roberts G, Sheridan B, Atkinson AB: Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegaly. Clin Endocrinol (Oxf) 1989;31:431-438.
49. Donath MY, Zierhut W, Gostelli-Peter MA, Hauri C, Froesch ER, Zapf J: Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat. Eur J Endocrinol 1998;139:109-117.
50. Donath MY, Gostelli-Peter MA, Hauri C, Froesch ER, Zapf J: Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic mRNA in rat heart. Eur J Endocrinol 1997;137:309-315.
51. Tanaka N, Ryoke T, Hongo M, Mao L, Rockman HA, Clark RG, Ross J Jr: Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am J Physiol 1998;275:H393-H399.
52. Harder BA, Schaub MC, Eppenberger HM, Eppenberger-Eberhardt M: Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture. J Mol Cell Cardiol 1996;28:19-31.
53. Tönshoff B, Nowack R, Kurilenko S, Blum WF, Seuberth HW, Mehls O, Ritz E: Growth hormone-induced glomerular hyperfiltration is dependent on vasodilating prostanoids. Am J Kidney Dis 1993;21:145-151.
54. Franco-Saenz R, Suzuki S, Tan SY, Mulrow PJ: Prostaglandin stimulation of renin release: independence of beta-adrenergic receptor activity and possible mechanism of action. Endocrinology 1980;106:1400-1405.